What if a clinical scan could transform biopharmaceutical innovation and patient care, streamlining drug development, clinical trials, and complex disease diagno...

No major scientific breakthrough comes without its challenges. This is certainly true of targeted protein degraders (TPDs), which have rapidly become one of the ...

Scientists have long understood that cancers are as individual as the patients in which they develop and proliferate. We still classify cancers in different grou...

Bioinformatics sits at the convergence of computational methods, life sciences, diagnostics and data analytics. Advances in computational power and efficiencies ...

While traditional small molecules excel at targeting buried active sites, they often struggle with flatter protein surface interactions. Macrocyclic compounds of...

Antibody-drug conjugates (ADCs) are one of the most rapidly expanding forms of oncology treatment and therapeutic successes have led to an unprecedented expansio...

Lipid nanoparticles (LNPs) are one of the most prominent tools for nucleic acid delivery. Their versatility allows the encapsulation of different cargos (siRNA, ...

Cell line development is a critical determinant of success in biologics manufacturing. It lays the foundation for product yield, quality and long-term process st...

Flexibility is an operational imperative in today’s fast-evolving biopharmaceutical industry. Contract development and manufacturing organisations (CDMOs), as in...

As biopharma therapies become more sensitive, costly and complex, traditional compliance frameworks are no longer enough. Real-time visibility and IoT innovation...